Table 2.
Cathepsin D inhibitors in chronological order.
| Inhibitor | Mechanism | Ref. |
|---|---|---|
| Natural Compounds | ||
| Pepstatin A from Actinomycetes | Non-competitive inhibitor | [141] |
| Cycloheximide from Streptomyces griseus | Protein synthesis inhibitor | [142] |
| The 22-kDa cathepsin D inhibitor protein of potatoes (PDI) from Solanum tuberosum | Reversible inhibitor | [143] |
| Equistatin from Actinia equina | Reversible inhibitor | [144] |
| Fucoidan from brown seaweeds and algae | Down-regulator of the expression | [126] |
| Oxymatrine from Sophora flavescens | Down-regulator of the expression | [125] |
| Morin hydrate from Maclura pomifera, Maclura tinctoria, Psidium guajava | Reversible inhibitor | [127] |
| Synthetic compounds | ||
| Dithiophosgene | Irreversible covalent inhibitor | [145] |
| 2,2-Dichloro-1,3-dithiacyclobutanone | ||
| Diazo compounds | Irreversible covalent inhibitor | [146] |
| Pro-Pro-Phe-Phe-Val-D-Leu | Reversible inhibitor | [147] |
| Cbz-Val-Val-(3S4S)-statine | Reversible inhibitor | [148] |
| Ibu-His-Pro-Phe-HCys-Sta-Leu-NH-[CH2]2-S-Acm | Reversible inhibitor | [149] |
| Derivatives of 4-(morpholinylsulphonyl)-L-Phe-P2-(cyclohexyl)Ala psi[isostere]-P1′-P2′ | Irreversible covalent inhibitor | [150] |
| Lentiviral shRNA constructs | RNA interference inhibitor | [76] |
| Acylguanidines | Reversible inhibitor | [131,132] |
| LY2811376 | Reversible inhibitor | [128] |
| PtdIns(3)P 1 RNA aptamer | Inhibitor of PtdIns(3)P | [136] |
| Macrocyclic inhibitors | Competitive inhibitor | [36] |
| Necrostatin-1 | Suppressor of activity | [130] |
| Polytherapy | ||
| RL2 2, with chloroquine, Ku55933, and rapamycin from Streptomyces hygroscopicus | Suppressor of activity | [134] |
| Praeruptorin C from Peucedanum praeruptorum and U0126 | Inhibitor through ERK1/2 3 signaling pathway | [133] |
1 phospatidylinositol 3-phosphate; 2 recombinant analog of human milk protein lactaptin; 3 extracellular signal-regulated kinase 1/2.